Over-the-counter medication · Mineral Supplement
chromium picolinate
Also sold as Chromium. This supplement is used to provide support to the pancreas.
Data updated 2026-05-15
- OTC
- Availability
chromium picolinate (Chromium) is an over-the-counter Mineral Supplement. This supplement is used to provide support to the pancreas.
Chromium picolinate is a mineral supplement. It is used to support the pancreas.
Verify with FDA → · CMS NADAC pricing →
What it does
This supplement is used to provide support to the pancreas.
Common side effects
No common side effects listed.
Key warnings
This product's claims have not been evaluated by the FDA.
The sections below are summarized in plain English from chromium picolinate's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
This product is a mineral supplement. It is intended to provide nutritional support. It is not evaluated by the FDA.
Serious Warnings
This product's claims have not been evaluated by the FDA.
Common Questions
What is chromium picolinate?
What does it do?
How much should adults take?
How much should children take?
Do I need a prescription?
Has the FDA evaluated this product?
Can I take this if I am pregnant?
Can I take this if I am breastfeeding?
What should I do if I miss a dose?
How should I store this product?
What drug class is chromium picolinate?
Related Medications in Mineral Supplement
Other drugs grouped near chromium picolinate - same-class peers and common alternatives.
ascorbic acid
Vitamin C
This medicine is a Vitamin C supplement.
Compare with chromium picolinate →
biotin
Vitamin B7
Dialyvite with Zinc is a prescription vitamin supplement.
Compare with chromium picolinate →
calcitriol
Rocaltrol
Calcitriol is a form of vitamin D that helps your body absorb and use calcium.
Compare with chromium picolinate →
calcium carbonate
Tums, Caltrate
Calcium carbonate is a medicine that can relieve heartburn and upset stomach.
Compare with chromium picolinate →
cholecalciferol
Vitamin D3
PNV-DHA is a multivitamin with minerals and essential fatty acids.
Compare with chromium picolinate →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Pain Relievers Compared
NSAIDs vs acetaminophen, which OTC pain reliever to use
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
What the FDA Data Shows for chromium picolinate
The FDA label for chromium picolinate (sold under brand names such as Chromium) classifies it as an over-the-counter product in the Mineral Supplement class. This supplement is used to provide support to the pancreas. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. Interaction data is drawn directly from FDA-approved prescribing information. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: March 27, 2023
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages